share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

SEC announcement ·  Jun 5 05:18
Summary by Futu AI
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a sale of company stock on June 3, 2024. The transaction involved the sale of 122 shares of Moderna's common stock at a price of $140.72 per share, resulting in a total sale value of $17,167.82. This sale followed an acquisition of 232 shares through the exercise of derivative securities on May 31, 2024. After these transactions, Klinger's direct holdings in Moderna stock amounted to 10,878 shares. The sale was conducted as an open market or private sale, according to the transaction details provided.
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a sale of company stock on June 3, 2024. The transaction involved the sale of 122 shares of Moderna's common stock at a price of $140.72 per share, resulting in a total sale value of $17,167.82. This sale followed an acquisition of 232 shares through the exercise of derivative securities on May 31, 2024. After these transactions, Klinger's direct holdings in Moderna stock amounted to 10,878 shares. The sale was conducted as an open market or private sale, according to the transaction details provided.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.